321 related articles for article (PubMed ID: 10497898)
1. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.
Connor TJ; Kelliher P; Harkin A; Kelly JP; Leonard BE
Eur J Pharmacol; 1999 Aug; 379(2-3):125-33. PubMed ID: 10497898
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
Cryan JF; Page ME; Lucki I
Eur J Pharmacol; 2002 Feb; 436(3):197-205. PubMed ID: 11858799
[TBL] [Abstract][Full Text] [Related]
3. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test.
Connor TJ; Kelliher P; Shen Y; Harkin A; Kelly JP; Leonard BE
Pharmacol Biochem Behav; 2000 Apr; 65(4):591-7. PubMed ID: 10764911
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
Page ME; Brown K; Lucki I
Psychopharmacology (Berl); 2003 Jan; 165(2):194-201. PubMed ID: 12426668
[TBL] [Abstract][Full Text] [Related]
5. Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.
Kang S; Kim HJ; Kim HJ; Shin SK; Choi SH; Lee MS; Shin KH
Eur J Pharmacol; 2010 Nov; 647(1-3):110-6. PubMed ID: 20826136
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
Page ME; Lucki I
Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
[TBL] [Abstract][Full Text] [Related]
7. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
8. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Cryan JF; Page ME; Lucki I
Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
[TBL] [Abstract][Full Text] [Related]
9. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
Andreasen JT; Redrobe JP
Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
[TBL] [Abstract][Full Text] [Related]
10. Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test.
Finn DP; Martí O; Harbuz MS; Vallès A; Belda X; Márquez C; Jessop DS; Lalies MD; Armario A; Nutt DJ; Hudson AL
Psychopharmacology (Berl); 2003 May; 167(2):195-202. PubMed ID: 12652345
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants differentially affect striatal amphetamine-stimulated dopamine and serotonin release in rats with high and low novelty-oriented behaviour.
O'Leary A; Kõiv K; Raudkivi K; Harro J
Pharmacol Res; 2016 Nov; 113(Pt B):739-746. PubMed ID: 26920253
[TBL] [Abstract][Full Text] [Related]
13. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
[TBL] [Abstract][Full Text] [Related]
14. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
Wong EH; Sonders MS; Amara SG; Tinholt PM; Piercey MF; Hoffmann WP; Hyslop DK; Franklin S; Porsolt RD; Bonsignori A; Carfagna N; McArthur RA
Biol Psychiatry; 2000 May; 47(9):818-29. PubMed ID: 10812041
[TBL] [Abstract][Full Text] [Related]
15. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
Bekris S; Antoniou K; Daskas S; Papadopoulou-Daifoti Z
Behav Brain Res; 2005 Jun; 161(1):45-59. PubMed ID: 15904709
[TBL] [Abstract][Full Text] [Related]
16. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Takahashi E; Katayama M; Niimi K; Itakura C
Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
[TBL] [Abstract][Full Text] [Related]
18. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
Masana M; Castañé A; Santana N; Bortolozzi A; Artigas F
Neuropharmacology; 2012 Sep; 63(4):675-84. PubMed ID: 22652058
[TBL] [Abstract][Full Text] [Related]
20. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.
Ulak G; Mutlu O; Akar FY; Komsuoğlu FI; Tanyeri P; Erden BF
Pharmacol Biochem Behav; 2008 Oct; 90(4):563-8. PubMed ID: 18565575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
